KPRX - KIORA PHARMACEUTICALS INC
3.3
0.037 1.130%
Share volume: 4,438
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$3.26
0.04
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-08-2024 | 03-25-2025 | |
| Total revenue | 16.000 M | 20.000 K | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 16.000 M | 20.000 K | 0.000 | 0.000 | |
| -99.88% | -100.00% | nan% | |||
| Operating expenses | 2.790 M | 2.445 M | 2.698 M | 5.452 M | |
| Selling general and admin | 1.296 M | 1.538 M | 1.381 M | 1.327 M | |
| Research and development | 1.494 M | 906.680 K | 1.317 M | 4.125 M | |
| Total expenses | 2.778 M | 2.565 M | 3.602 M | 2.565 M | |
| -7.67% | 40.44% | -28.80% | |||
| Operating income | 13.222 M | -2.545 M | -3.602 M | -2.565 M | |
| Ebit | 13.230 M | -2.564 M | -3.662 M | -2.576 M | |
| Pretax income | 13.453 M | -2.222 M | -3.413 M | -2.158 M | |
| -116.51% | 53.64% | -36.76% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 13.453 M | -2.222 M | -3.413 M | -4.224 M | |
| -116.51% | -53.64% | -23.74% |
